Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?

Antiangiogenic therapy has shown promise in the treatment of patients with hepatocellular carcinoma (HCC). Bevacizumab, sorafenib, and sunitinib showed efficacy in patients with HCC; and sorafenib is approved by the FDA for treatment of this cancer. In practice, the clinical benefit of these agents...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Wenger, Justin B., Santos, Napoleon, Liu, Yanxia, Dallas, Jennifer, Subbiah, Sukanthini, Hochwald, Steven, Huang, Emina H., Dang, Duyen T., Allegra, Carmen J., Luesch, Hendrik, Dang, Long H.
Formáid: Artigo
Teanga:Inglês
Foilsithe: Springer Milan 2011
Ábhair:
Review
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3179415/
https://ncbi.nlm.nih.gov/pubmed/21949574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12156-011-0082-3
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla